Acquired Immunodeficiency Syndrome: all 3,037 studies
Page 23 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.
- ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to AtriplaCompletedNCT00615745Phase 4
- Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIVCompletedNCT00602758Not applicable
- AIDS and Cancer Specimen Bank (ACSB)CompletedNCT00587912
- Relationship Between HIV-1 Subtype and ARV ResponseCompletedNCT00585793
- CNS (Central Nervous System) Viral Dynamics and Cellular Immunity During AIDSCompletedNCT00583167
- Family Access to Care Study (FACS)CompletedNCT00582218
- Energy Specific Far Infrared Radiation Treatment for AIDSStatus unknownNCT00574522Phase 1
- Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAARTWithdrawnNCT00572429Not applicable
- Continuous Use of COCsCompletedNCT00570440Phase 4
- Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their ChildrenCompletedNCT00562874Not applicable
- Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV TherapyTerminatedNCT00559416Phase 1
- Effect of HIV/STD Risk Reduction Program on South African AdolescentsCompletedNCT00559403Phase 2/3
- Utilization of HIV Clinical Services in Rural IndiaCompletedNCT00554567Phase 3
- Motivation and Patch Treatment for HIV-positive SmokersCompletedNCT00551720Phase 3
- Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected PatientsCompletedNCT00551655
- Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)CompletedNCT00551330Phase 2
- Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDSCompletedNCT00546689
- Study of a Potential Preventive Vaccine Against HIV in Healthy VolunteersCompletedNCT00545987Phase 1
- The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive SubjectsCompletedNCT00540137Phase 4
- Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.CompletedNCT00540111Not applicable
- The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV PatientsStatus unknownNCT00536848Phase 2/3
- Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mgTerminatedNCT00533390Phase 4
- A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)Status unknownNCT00532974Phase 1
- Epoetin Alfa for HIV-Associated Neuropathy TrialWithdrawnNCT00528593Phase 2
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)CompletedNCT00523211Phase 3
- Integrase Inhibitor (MK-0518) Viral DecayCompletedNCT00520897Phase 2
- Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other ImmunodeficienciesCompletedNCT00517803Not applicable
- Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected PatientsStatus unknownNCT00517569Phase 1
- Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAARTCompletedNCT00516581
- Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV InfectionCompletedNCT00514605Phase 2/3
- TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) PreviouslyTerminatedNCT00513513Phase 2
- Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*CompletedNCT00511368Phase 2
- Smoking Cessation for HIV/AIDS PatientsCompletedNCT00502827Not applicable
- The Effect of Malaria on Disease Progression of HIV/AIDSCompletedNCT00499876Not applicable
- Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C VirusStatus unknownNCT00499434
- Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)CompletedNCT00495326Phase 2/3
- HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of BiomarkersCompletedNCT00491335
- Safety And Efficacy Study Of CP-675,206 In HIV-Infected PatientsWithdrawnNCT00488995Phase 2
- Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected PatientsCompletedNCT00483392Not applicable
- A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or BothCompletedNCT00480558Phase 1
- RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected PatientsStatus unknownNCT00480350Phase 2
- Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)CompletedNCT00474370Phase 3
- Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and ZidovudineCompletedNCT00471614Phase 2
- Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected PersonsCompletedNCT00463086Not applicable
- Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701CompletedNCT00453440
- Effect of Atazanavir on Endothelial Function in HIV-Infected PatientsCompletedNCT00447070Phase 4
- Effect of Repeated Exposures to Compressed Air on Patients With AIDSWithdrawnNCT00444847Phase 2
- Anti-Retrovirals for Kaposi's SarcomaCompletedNCT00444379Phase 4
- Computer Assisted Rx Education for HIV-Positives: CARE+CompletedNCT00443378Not applicable
- Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected PatientsCompletedNCT00441688Phase 4
- Pharmacogenetics of Antiretroviral DrugsCompletedNCT00435656
- Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load MonitoringCompletedNCT00434070
- Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous MeningitisStatus unknownNCT00433719Not applicable
- Long Term Treatment InterruptionsCompletedNCT00433056Phase 3
- Assessment of Asymptomatic Heart Disease in Children With HIVStatus unknownNCT00426374Not applicable
- Oral Human Papillomavirus Infection in HIV-infected MenStatus unknownNCT00421486
- Pharmacokinetic Study of Two HIV Protease Inhibitors in PatientsTerminatedNCT00420355Phase 4
- BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)TerminatedNCT00414284Phase 4
- TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected PatientsCompletedNCT00412646Phase 2
- FREE Study: Efficacy and Toxicity of TrizivirCompletedNCT00405925Phase 3
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With AnergyCompletedNCT00402610Phase 4
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium TuberculosisCompletedNCT00402454Phase 4
- Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected AdultsCompletedNCT00398125Phase 2
- Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical TrialsCompletedNCT00394004
- HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing StrategyCompletedNCT00393302
- Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected PatientsCompletedNCT00393120Phase 2
- Study to Reduce Intravenous Exposures (STRIVE)CompletedNCT00391482Phase 2/3
- Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV InfectionCompletedNCT00390078Phase 1/2
- BASIC: Boosted Atazanavir or Saquinavir Induced Lipid ChangesCompletedNCT00389402Phase 4
- Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV InfectionCompletedNCT00386633Phase 1
- A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects.CompletedNCT00386347Phase 1
- A Trial of PEHRG214 in HIV-Infected PatientsTerminatedNCT00385567Phase 2
- A Trial of Vitamins and HAART in HIV Disease ProgressionCompletedNCT00383669Phase 3
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- C2P - Phase III: MPowerment and Community PromiseCompletedNCT00381784Not applicable
- HIV Prevention in the Primary Care SettingCompletedNCT00381524Not applicable
- A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.CompletedNCT00381212Phase 1/2
- HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTCompletedNCT00380770Phase 4
- Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014ACompletedNCT00380159Phase 2
- Reducing Unsafe Alcohol Use in HIV-Positive IndividualsCompletedNCT00371969Not applicable
- SPL7013 Gel - Male Tolerance StudyCompletedNCT00370357Phase 1
- NOW Thai HAART StudyCompletedNCT00367731
- Directly Observed Antiretroviral Therapy Among Active Drug UsersCompletedNCT00367172Not applicable
- Treatment of Cerebral Toxoplasmosis in HIV/AIDSCompletedNCT00367081Phase 4
- Effectiveness of a Telephone-Delivered Behavioral Treatment to Improve the Quality of Life of Older Adults With HIVCompletedNCT00365690Phase 2/3
- Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected PatientsCompletedNCT00365612Phase 4
- Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)CompletedNCT00360932
- Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected PatientsCompletedNCT00358696Phase 4
- Improving HIV Prevention Skills in People With Serious Mental IllnessesCompletedNCT00356291Phase 2
- Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or TogetherCompletedNCT00352066Phase 1
- Preventive Therapy for Tuberculosis in HIV Infected PersonsCompletedNCT00351702Phase 3
- Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian PopulationsWithdrawnNCT00347750
- Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral SuppressionCompletedNCT00344981Not applicable
- Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From PrisonCompletedNCT00344591Phase 2
- Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
- Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency SyndromeCompletedNCT00342602
- Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, UgandaCompletedNCT00342160
- Epidemiological Study of HIV in the South African National Defense ForceTerminatedNCT00341887
- Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in IndiaCompletedNCT00341796
- The Second Multicenter Hemophilia Cohort StudyCompletedNCT00341705